NCPA’s Ronna Hauser, senior vice president of policy and pharmacy affairs, talks with Antonio Ciaccia, president of 3 Axis Advisors, about his firm’s newest research on how the Medicare Drug Price Negotiation Program will leave independent pharmacies high and dry.
